Loading…
Nu Skin Enterprises, Inc. is projected to rise to $7.48 by 2027, a +24% move from its current price of $6.02. NUS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.89 | $6.02 | $6.16 | +0.04% |
| May 30 | $5.84 | $6.03 | $6.22 | +0.09% |
| May 31 | $5.80 | $6.03 | $6.26 | +0.13% |
| Jun 1 | $5.77 | $6.03 | $6.30 | +0.18% |
| Jun 2 | $5.74 | $6.03 | $6.34 | +0.22% |
| Jun 3 | $5.72 | $6.04 | $6.37 | +0.27% |
| Jun 4 | $5.70 | $6.04 | $6.40 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.70 | $6.04 | $6.40 | +0.31% |
| Week 2 | $5.58 | $6.06 | $6.58 | +0.63% |
| Week 3 | $5.50 | $6.08 | $6.72 | +0.94% |
| Week 4 | $5.43 | $6.10 | $6.85 | +1.26% |
| Week 5 | $5.37 | $6.12 | $6.96 | +1.58% |
| Week 6 | $5.32 | $6.13 | $7.07 | +1.90% |
| Week 7 | $5.28 | $6.15 | $7.17 | +2.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nu Skin Enterprises, Inc. is a global company that develops and distributes beauty and wellness products through its subsidiaries. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. It engages in research and product development across skin care products, nutritional supplements, and devices. Products are sold under Nu Skin, Pharmanex, and ageLOC brands through retail stores, websites, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers.
It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Nu Skin Enterprises, Inc. (NUS) trades at $5.93, with a market cap of $287.9M and a rank of 3569. The current price and market position place it among smaller-cap consumer defensive names with a global footprint in beauty and wellness products.
A major floor 27.9% below — a decisive break under it would weaken the trend.
The nearest floor, 5.3% below — buyers have tended to step in here.
The nearest ceiling, 31.2% above — a clean break opens room to run.
A major ceiling 91.7% above — clearing it would confirm fresh momentum.
Key NUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.92 | Buy | $5.96 | Buy |
| MA 10 | $5.98 | Buy | $6.09 | Sell |
| MA 20 | $6.53 | Sell | $6.42 | Sell |
| MA 50 | $7.06 | Sell | $7.09 | Sell |
| MA 100 | $8.26 | Sell | $7.88 | Sell |
| MA 200 | $9.58 | Sell | $8.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.95 | Neutral |
| Stoch RSI (14) | 56.20 | Neutral |
| CCI (20) | -62.13 | Neutral |
| Williams %R (14) | -78.08 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -15.92 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 21.92 | Neutral |
| TRIX (15) | -0.75 | Sell |
| Awesome (5,34) | -1.05 | Sell |
| Ultimate (7,14,28) | 35.61 | Neutral |
| Momentum (10) | -0.53 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 5.93 | Buy |
| ADX (14) | 31.85 | Sell |
| ATR (14) | 0.14 | Info |
In the near term, the technical picture is NEUTRAL. The RSI14 is 30, and the price is trading around the 30-day window. The stock is currently below its key moving averages, with a 30-day range of $5.10 to $6.89.
The price is below the SMA50 of $7.11 and the SMA200 of $9.61, suggesting limited near-term upside without catalysts. Support sits at $5.70, with resistance at $7.90, helping define potential short-term basing levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.70 | $6.02 | $8.47 | 0% | Neutral | |
| $6.05 | $7.48 | $9.74 | +24% | Bullish | |
| $6.30 | $7.96 | $10.66 | +32% | Bullish | |
| $6.08 | $7.83 | $10.74 | +30% | Bullish | |
| $6.16 | $8.05 | $11.27 | +34% | Bullish | |
| $6.17 | $8.18 | $11.65 | +36% | Bullish | |
| $6.35 | $8.54 | $12.35 | +42% | Bullish | |
| $7.69 | $10.46 | $15.35 | +74% | Bullish | |
| $7.90 | $10.87 | $16.18 | +81% | Bullish | |
| $7.49 | $10.42 | $15.69 | +73% | Bullish | |
| $9.91 | $14.51 | $23.02 | +141% | Bullish | |
| $14.61 | $23.27 | $39.89 | +287% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.70 | $6.02 | $7.06 | +0.00% |
| June 2026 | $5.31 | $6.21 | $7.41 | +3.09% |
| July 2026 | $5.33 | $6.27 | $7.57 | +1.05% |
| August 2026 | $5.29 | $6.26 | $7.62 | -0.15% |
| September 2026 | $5.46 | $6.49 | $7.95 | +3.67% |
| October 2026 | $5.67 | $6.77 | $8.34 | +4.25% |
| November 2026 | $5.66 | $6.78 | $8.40 | +0.18% |
| December 2026 | $5.66 | $6.80 | $8.47 | +0.31% |
Click any year to see its month-by-month NUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NUS price prediction for 2026 points to an average of $6.02 (low $5.70, high $8.47) — a potential gain of 0% on today's $6.02. A consolidation phase looks the most probable path here.
In 2027, NUS is projected to trade between $6.05 and $9.74, averaging $7.48 — a potential gain of +24% from today's $6.02. That is up +24% on the projected 2026 average. Momentum favours further upside here.
Nu Skin Enterprises, Inc.'s 2028 outlook centres on $7.96, within a $6.30 to $10.66 range. That is up +6% on the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NUS could reach as high as $10.74, with a base case around $7.83 and support toward $6.08 — roughly +30% from $6.02. Momentum favours further upside here.
Expect NUS to range from $6.16 to $11.27 through 2030. The $8.05 average target implies a +34% move from current prices. That is up +3% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The NUS price prediction for 2031 points to an average of $8.18 (low $6.17, high $11.65) — a potential gain of +36% on today's $6.02. Momentum favours further upside here.
In 2032, NUS is projected to trade between $6.35 and $12.35, averaging $8.54 — a potential gain of +42% from today's $6.02. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Nu Skin Enterprises, Inc.'s 2033 outlook centres on $10.46, within a $7.69 to $15.35 range. That is up +23% on the projected 2032 average. That marks a +74% change versus current levels. Momentum favours further upside here.
By 2034, NUS could reach as high as $16.18, with a base case around $10.87 and support toward $7.90 — roughly +81% from $6.02. Buyers look set to stay in control over this stretch.
Expect NUS to range from $7.49 to $15.69 through 2035. The $10.42 average target implies a +73% move from current prices. That is -4% versus the projected 2034 average. Momentum favours further upside here.
The NUS price prediction for 2040 points to an average of $14.51 (low $9.91, high $23.02) — a potential gain of +141% on today's $6.02. Buyers look set to stay in control over this stretch.
In 2050, NUS is projected to trade between $14.61 and $39.89, averaging $23.27 — a potential gain of +287% from today's $6.02. That is up +60% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NUS today (≈ 166.112957 NUS) could be worth
$3,865.59
+$2,865.59 (+287%) by 2050 · US Dollar
Based on the average projected NUS price of $23.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUSwould be worth at today's price.
$1,000 invested in NUS on May 27, 2025 (≈ 132.100393 NUS) would be worth
$795.24
-$204.76 (-20.5%) today · 0.80× · US Dollar
Based on a NUS entry price of $7.57 vs. today's $6.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.84 | $1,030.82 | +3.1% |
| 1 month ago | $7.48 | $804.81 | -19.5% |
| 3 months ago | $8.63 | $697.57 | -30.2% |
| 6 months ago | $9.89 | $608.7 | -39.1% |
| 1 year ago | $7.57 | $795.24 | -20.5% |
| All time (5.0y) ago | $60.93 | $98.8 | -90.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUS forecast.
Our base-case forecast reaches $12.00 around 2040.
Implied market cap at $12.00: $582.61M
The multi-year forecast shows bullish potential beyond 2026. For 2026 the min, avg, and max are $5.70, $5.93, and $8.47 respectively, with an ROI of 0 and sentiment NEUTRAL. From 2027 onward, the outlook improves, with 2027 avg $7.46 (ROI 25.8%, BULLISH), 2028 avg $7.90 (ROI 33.3%, BULLISH), 2029 avg $7.84 (ROI 32.2%, BULLISH), 2030 avg $8.04 (ROI 35.6%, BULLISH), 2031 avg $8.15 (ROI 37.5%, BULLISH), 2032 avg $8.65 (ROI 45.8%, BULLISH), 2033 avg $10.61 (ROI 78.8%, BULLISH), 2034 avg $10.95 (ROI 84.6%, BULLISH), 2035 avg $10.52 (ROI 77.3%, BULLISH).
The bullish trajectory continues with 2040 avg $14.72 (ROI 148.2%, BULLISH) and 2050 avg $23.84 (ROI 302.1%, BULLISH). These figures are estimates and not guarantees, and reflect a long-run upside potential with associated risks.
Tap a question to reveal the answer.
Avg $8.04; min $6.12; max $11.33; ROI 35.6%; sentiment BULLISH. These are estimates, not guarantees.
The forecast turns BULLISH from 2027 onward, with rising averages and ROIs (2027 Avg $7.46, ROI 25.8%; 2028 Avg $7.90, ROI 33.3%; 2029 Avg $7.84, ROI 32.2%; 2030 Avg $8.04, ROI 35.6%). The 2026 forecast is NEUTRAL (Avg $5.93, ROI 0). These are estimates, not guarantees.
No. The max forecast shown through 2050 is $41.36 (Avg $23.84, ROI 302.1%), not $50. These are estimates, not guarantees.
Current price is $5.93. The 30-day range is $5.10 to $6.89, RSI14 is 30, with support at $5.70 and resistance at $7.90. These are estimates, not guarantees.
Market cap $287.9M; rank 3569. These are estimates, not guarantees.
Nu Skin Enterprises, Inc. Community Discussion
0Share your Nu Skin Enterprises, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.